News
Ianalumab is a fully human monoclonal antibody designed to deplete B cells via antibody-dependent cellular toxicity and inhibit BAFF-R-mediated signals of B cell function and survival.
A total of 237 estimates from 47 studies covering more than 1.5 million cases of any ethnicity were included in the study.
Researchers compared the severity of gastrointestinal and psychological symptoms between cisgender heterosexual and sexual gender minorities with IBS.
Treatment was linked to reduced rates of first occurrence of suicidal behaviors, substance misuse, transport accidents, and criminality.
Researchers found that 46.4% said they would accept one or more missing vaccines if they could be provided during their ED visit.
Researchers assessed the effect of hepatitis B virus infection on the outcomes of assisted reproductive technology among women.
The researchers found that 14 gut bacterial taxa may contribute to the risks for insomnia, while a protective effect on this condition was seen for 8 gut bacterial taxa. HealthDay News — There appear ...
The CDC reported that wastewater activity for COVID-19 has climbed to a “moderate” level nationwide, up from “low” the week before.
The Food and Drug Administration (FDA) has approved Brinsupri ™ (brensocatib) for the treatment of non-cystic fibrosis bronchiectasis (NCFB) in adult and pediatric patients aged 12 years and older.
“While Ebstein anomaly is most often classified as a cardiac lesion associated with a moderate risk of cardiac event in pregnancy, our data support the risks of arrhythmia and heart failure are high ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results